Cevostamab Following CAR T Cell Therapy for RRMM
Clinical trial NCT05801939 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05801939
- Sponsor
- University of Pennsylvania
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-11
- Primary completion
- 2027-05-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.